ACST trade ideas

RedHotStocks

Possible entry above $ 0.6563 Target price $ 0.8193

JoshW04

Get in at $.53. SL at $.48. TP $.65.

shkspr

NASDAQ:ACST Possible Scenario: LONG Evidence: Price Action This is my idea and could be wrong100% * Huge profit opportunity, not a trade advise

Vibranium_Capital

looks like a good dip buy on RSI but id wait for the downtrend to break for a 0-2 day scalp play on this one, ideal entry is .61, stop loss at .5 and target at 1-1.5, some great risk reward ! goodluck :) remember to always to small size on penny stocks too !

Bullishcharts

Long s may look to add above the 200ma @ $0.4458 Targets $0.5652 major pivot $.6450 gap fill

JoshW04

Get in at $.30. SL at $.27. 1st TP at $.35. Could Break to $.50

ram10kk Updated 

Gap Fill play - Play small Qty see boxes on chart for Entry, Exit and Stop loss zones.

DEXWireNews

Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.

Bullwards

This idea is based on my technical analysis only. Do your research and trade on your own risk!

nathanielx9

ACST has been in a rising wedge in a bullish pattern and high buy volume. Still long

nathanielx9 Updated 

So today I sold my NCLH and Bitcoin and went into ACST or Acasti Pharma. We made nice gains with NCLH with a killer premarket but leveled off back under closed, but than exploded 6% and going even higher after I sold at 11.22 with my buy at 9.88. Bitcoin has been bouncing between 1-2%, which had nice support at the emas this morning. is why ACST also caught my...

mauretto432

ACST = 50000 from 0.78$ to 1.7$ in one mounth max 98% GAIN

whoelse

Wave C of Wave 1 of larger degree is in the process of price correction to slightly below $1 as basing level for the start of Wave 3, beggining at $1.

DEXWireNews

On the verge of a breakout we get a dump of over 250,000 shares just as the stock is halted for news pending. Someone looks to have got some info before everyone else.

Bullishcharts

OUR PREVIOUS PRICE TARGET HIT AND NOW LOOKING TO BOOK SOME GAINS ON THE BREAKOUT.

Bullishcharts

Entry level $2.14 = Target price $2.39 = Stop loss $2.03 Average analysts pricer target $5.20 | Buy Company profile Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill...

Capitalist-Pig

?

DEXWireNews

Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada. Average...